Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184-1192

Diabetes Care. 2022 Dec 1;45(12):e181. doi: 10.2337/dc22-0701.

Authors

Cheng-Hsien Hung¹, Fu-Shun Yen², James Cheng-Chung Wei^{3

4

5}

Affiliations

¹ Department of Pharmacy, Chang Bing Show Chwan Memorial Hospital, Changhua, Taiwan.
² Dr. Yen's Clinic, Taoyuan, Taiwan.
³ Department of Allergy, Immunology, and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
⁴ Institute of Medicine, College of Medicine, Chung Shan Medical University, Taichung, Taiwan.
⁵ Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.

PMID: 36455119
DOI: 10.2337/dc22-0701

No abstract available

Publication types

Letter
Comment

MeSH terms

Atherosclerosis* / prevention & control
Cardiovascular Diseases*
Diabetes Mellitus, Type 2* / complications
Humans
Ischemia
Ischemic Stroke*